PSFE vs CLOV

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Aug 02, 2026

PSFE

48.6
AI Score
VS
CLOV Wins

CLOV

48.9
AI Score

Investment Advisor Scores

PSFE

49score
Recommendation
HOLD

CLOV

49score
Recommendation
HOLD

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric PSFE CLOV Winner
Revenue 442.72M 749.19M CLOV
Net Income -36.45M 27.33M CLOV
Net Margin -8.2% 3.6% CLOV
Operating Income 1.08M 27.33M CLOV
ROE -5.9% 8.1% CLOV
ROA -0.8% 3.9% CLOV
Total Assets 4.66B 697.73M PSFE
Current Ratio 1.16 1.33 CLOV
Free Cash Flow 63.35M 107.04M CLOV

Relative Price Performance (Last 90 Days)

PSFE 1M: +2.5% · 3M: -10.6% CLOV 1M: -22.6% · 3M: +51.6%

Current Technical Phase

PSFE

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 50

RSI (14): 50.4 · Price: $8.08

CLOV

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 41

RSI (14): 41.3 · Price: $4.17

Fundamentals Snapshot

Metric PSFE CLOV
Market Cap
Forward P/E 3.2 41.7
Trailing P/E
Revenue (TTM)
Revenue Growth 0.1% 0.6%
Gross Margin 0.6% 0.2%
Operating Margin 0.0% 0.0%
EPS -3.45 -0.12
Dividend Yield

Frequently Asked Questions

Based on our detailed analysis, CLOV is currently the stronger investment candidate, winning 8 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.